Clinical Trials Directory

Trials / Completed

CompletedNCT06491836

Oligoantigenic Diet and Core Symptomatology of Children With Attention-Deficit /Hyperactivity Disorder (ADHD).

The Effect of an Oligoantigenic Diet on Core Symptomatology of Children With Attention-Deficit /Hyperactivity Disorder (ADHD).

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
6 Years – 16 Years
Healthy volunteers
Not accepted

Summary

Fifty patients who diagnosed as ADHD syndrome according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM 5) Criteria aged from 6 to 16 years old will be assigned randomly into 2 arms: arm 1: the patients will follow food regimen that cover recommended daily allowance (RDA) for macronutrients and micronutrients suitable for their ages without any food restriction, arm 2: the patients will follow food regimen that cover (RDA) for macronutrients and micronutrients suitable for their ages based on Oligoantigenic diet (OAD). Psychiatric assessment will be done before intervention and after 3 months of intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENToligoantigenic dietOligoantigenic diet that will cover recommended daily allowance (RDA) of macronutrients and micronutrients according patients' ages according to our available sources of food in our culture and the diet consists typically of meat (e.g. chicken and lamb), carbohydrate sources (e.g., potatoes and rice), fruits (e.g., bananas, pears and apples), vegetables (e.g., cucumbers, carrot, lettuce, cauliflower, turnips, cabbage and broccoli)
OTHERFood regimen without food restrictions.Food regimen that will cover recommended daily allowance (RDA) for macronutrients and micronutrients according patients' ages without any food restriction

Timeline

Start date
2024-09-01
Primary completion
2025-10-01
Completion
2025-11-15
First posted
2024-07-09
Last updated
2025-12-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06491836. Inclusion in this directory is not an endorsement.